A
OCUL icon

AJOVista’s Ocular Therapeutix OCUL Stock Holding History

AJOVista’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$96.8K Buy
+11,123
New +$91.7K 0.41% 76

Other funds holding OCUL

SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

AJOVista's OCUL Position: Q3 2024 in Review

AJOVista opened a new position in Ocular Therapeutix (OCUL) in Q3 2024: 11,123 shares worth $96.8K. The stake represents 0.41% of the portfolio and ranks #76 among its holdings.

168 funds tracked by Wall St. Rank hold OCUL as of Q3 2024.

  • AJOVista held 11,123 shares of Ocular Therapeutix worth $96.8K as of Q3 2024.
  • Ocular Therapeutix was a new AJOVista position in Q3 2024.
  • Ocular Therapeutix made up 0.41% of AJOVista's portfolio in Q3 2024, its #76 holding.
  • 168 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2024.

Based on AJOVista's 13F filing for Q3 2024, filed 12 Nov 2024.